Philips Sleep Apnea Deal Leaves Opening for Future Cancer Claims
Royal Philips NV’s $1.1 billion settlement of US lawsuits targeting 5.5 million recalled sleep-apnea devices resolves only current cases and doesn’t set aside funds for potential future cancer claims over the machines.